Successful completion of USFDA inspection at Alembic Pharmaceuticals Limited’ Oral Solid Formulation Facility (F-I) at Panelav

29 July 2024 – Bengaluru: Alembic Pharmaceuticals Limited announced that it has successfully completed the United States Food and Drug Administration (USFDA) inspection for its Oral Solid Formulation Facility (F-I) located at Panelav.

This was a scheduled GMP inspection and was successfully completed without any Form 483 observation. The inspection was conducted from 17^th July, 2024 to 26^th July, 2024.